SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-022464
Filing Date
2023-04-04
Accepted
2023-04-04 08:31:36
Documents
2
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1610
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4515
  Complete submission text file 0001209191-23-022464.txt   7600
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Winton Matthew (Reporting) CIK: 0001971400 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39397 | Film No.: 23795185